Synonyms: example 7i [US8501735]
Compound class:
Synthetic organic
Comment: The chemical structure for frevecitinib was obtained from proposed INN list 130 (Feb. 2024), in which the compound is described as a Janus kinase inhibitor with anti-inflammatory potential. The structure matched example 7i in Palau Pharma's patent US8501735 [1].
|
|
References |
1. Rosales CA, Solana JS, Soliva RS, Escrich SR, González MCS. (2013)
N-containing heteroaryl derivatives as JAK3 kinase inhibitors. Patent number: US8501735B2. Assignee: Palau Pharma SA. Priority date: 29/10/2010. Publication date: 06/08/2013. |